1-5 of 5
Lyndah Dreiling
Close
Sort by
Journal Articles

Clinical and Radiographic Evaluation of Spleen Size during Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim: Results of an Open-Label Trial in Normal Donors.

Patrick J. Stiff, MD, William Bensinger, MD, Muneer H. Abidi, MD, Roger Gingrich, MD, Andrew S. Artz, MD, Wade Lovelace, Matthew Guo, PhD, Lyndah Dreiling, MD
Journal: Blood
Blood (2007) 110 (11): 477.
https://doi.org/10.1182/blood.V110.11.477.477
Published: 2007
Journal Articles

Final Results of a Large, Community Based Study Evaluating the Impact of First and Subsequent Cycle Pegfilgrastim on Neutropenic Events in NHL and HD Patients.

Stephen J. Noga, MD, Janak Choksi, MD, Beiying Ding, PhD, Lyndah Dreiling, MD, Howard Ozer, MD
Journal: Blood
Blood (2006) 108 (11): 1153.
https://doi.org/10.1182/blood.V108.11.1153.1153
Published: 2006
Journal Articles

The Efficacy and Safety of Darbepoetin Alfa for Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Results after 53/55 Weeks.

Janice Gabrilove, MD, Ronald Paquette, MD, Roger M. Lyons, MD, Chaudhry Mushtaq, MD, Mikkael A. Sekeres, MD, Hung Lam, PhD, Lyndah Dreiling, PhD
Journal: Blood
Blood (2006) 108 (11): 2671.
https://doi.org/10.1182/blood.V108.11.2671.2671
Published: 2006
Journal Articles

Bone Marrow Reticulin in Patients with Immune Thrombocytopenic Purpura.

Ghulam Mufti, Adam Bagg, Robert Hasserjian, Barbara Bain, David Kuter, Lyndah Dreiling, Janet Nichol
Journal: Blood
Blood (2006) 108 (11): 3982.
https://doi.org/10.1182/blood.V108.11.3982.3982
Published: 2006
Journal Articles

A Phase 2, Single-Arm, Open-Label Trial To Evaluate the Effectiveness of Darbepoetin alfa for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndrome.

Janice Gabrilove, Ron Paquette, Roger Lyons, Chaudhry Mushtaq, Mikkael Sekeres, Hung Lam, Lyndah Dreiling
Journal: Blood
Blood (2005) 106 (11): 2541.
https://doi.org/10.1182/blood.V106.11.2541.2541
Published: 2005